{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:56:00Z","timestamp":1791168960596,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T17:29:34Z","timestamp":1408123774000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Antonella","family":"Ferrante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pepponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beggiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Tebano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.013_bb0005","first-page":"195","article-title":"Neurotrophic factors in Huntington's disease","volume":"146","author":"Alberch","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2014.08.013_bb0010","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","article-title":"Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively","volume":"23","author":"Alfinito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"15","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2014.08.013_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(97)00348-X","article-title":"Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide","volume":"762","author":"Barth","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.08.013_bb0025","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1523\/JNEUROSCI.22-20-09122.2002","article-title":"The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity","volume":"22","author":"Blum","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0512","article-title":"Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease","volume":"10","author":"Blum","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0035","doi-asserted-by":"crossref","first-page":"12427","DOI":"10.1523\/JNEUROSCI.4052-06.2006","article-title":"p38 mitogen-activated protein kinase contributes to adenosine A1 receptor-mediated synaptic depression in area CA1 of the rat hippocampus","volume":"26","author":"Brust","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0040","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1523\/JNEUROSCI.17-12-04509.1997","article-title":"Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses","volume":"17","author":"Calabresi","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.08.013_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(96)00023-3","article-title":"Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors","volume":"380","author":"Ciruela","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2014.08.013_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","article-title":"MAP kinase pathways","volume":"71","author":"Cobb","year":"1999","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2014.08.013_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.nbd.2014.08.013_bb0090","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/0929867023368917","article-title":"Adenosine A1 receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system","volume":"9","author":"Dalpiaz","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.013_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2013.11.013","article-title":"Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice","volume":"62","author":"Dau","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-199505300-00006","article-title":"Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation","volume":"6","author":"de Mendon\u00e7a","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2014.08.013_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington's disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2014.08.013_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.nbd.2011.12.019","article-title":"P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease","volume":"45","author":"Fan","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-010-0389-4","article-title":"Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes; a novel action of cocaine","volume":"117","author":"Ferraro","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2014.08.013_bb0145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.08.013_bb0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0165-6147(88)90194-0","article-title":"How does adenosine inhibit transmitter release?","volume":"9","author":"Fredholm","year":"1988","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International union of pharmacology XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2014.08.013_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2014.08.013_bb0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.013_bb0180","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1152\/jn.1994.72.5.2360","article-title":"GABAb and adenosine receptors mediate enhancement of the K+ current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons","volume":"72","author":"Gerber","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0190","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease","volume":"20","author":"Giralt","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.013_bb0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.013_bb0200","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/mol.106.030718","article-title":"Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate","volume":"71","author":"Gomez-Lazaro","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1471-4159.2008.05602.x","article-title":"Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)-pia binding to the caudate nucleus","volume":"107","author":"Gracia","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002100000314","article-title":"Functions of neuronal adenosine receptors","volume":"362","author":"Haas","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00194305","article-title":"The epidemiology of Huntington's disease","volume":"89","author":"Harper","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.nbd.2014.08.013_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutics targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2014.08.013_bb0230","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/bbrc.1999.1454","article-title":"Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase","volume":"263","author":"Kumar","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.08.013_bb0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)01890-3","article-title":"The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury","volume":"447","author":"Legos","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1600-0404.2003.00129.x","article-title":"Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia","volume":"108","author":"Lennmyr","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2014.08.013_bb0245","first-page":"1","article-title":"Multiple pathways contribute to the pathogenesis of Huntington disease","volume":"16","author":"Li","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.08.013_bb0250","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2004.07.113","article-title":"Adenosine A1-receptor-mediated tonic inhibition of glutamate release at rat hippocampal CA3\u2013CA1 synapses is primarily due to inhibition of N-type Ca2+ channels","volume":"499","author":"Manita","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","article-title":"Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice","volume":"417","author":"Martire","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.08.013_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2009.09.012","article-title":"Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice","volume":"37","author":"Martire","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jnc.12177","article-title":"BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved","volume":"125","author":"Martire","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.013_bb0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0301-0082(99)00019-2","article-title":"The selective vulnerability of striatopallidal neurons","volume":"59","author":"Mitchell","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2014.08.013_bb0290","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.WCB.0000084251.20114.65","article-title":"Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance","volume":"23","author":"Nishimura","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2014.08.013_bb0295","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.2174\/092986711797535335","article-title":"Adenosine A(1) receptors in the central nervous system: their functions in health and disease, and possible elucidation by PET imaging","volume":"18","author":"Paul","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0305","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","article-title":"A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington's disease","volume":"14","author":"Popoli","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2014.08.013_bb0315","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0953-816X.2003.03131.x","article-title":"The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin","volume":"19","author":"Rangone","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.013_bb0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuint.2005.05.009","article-title":"Different roles of adenosine A1, A2A and A3 receptors in controlling kainite-induced toxicity in cortical cultured neurons","volume":"47","author":"Rebola","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2014.08.013_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","article-title":"Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.08.013_bb0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2014.08.013_bb0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(01)00761-0","article-title":"Regulation of p42\/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells","volume":"41","author":"Robinson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0340","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","article-title":"Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease \u2014 from clinical features to the bench","volume":"11","author":"Rosenstock","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.nbd.2014.08.013_bb0345","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1074\/jbc.273.28.17610","article-title":"Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization","volume":"273","author":"Saura","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0350","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0896-6273(92)90134-Y","article-title":"Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses","volume":"8","author":"Scholz","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.013_bb0355","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1523\/JNEUROSCI.14-09-05325.1994","article-title":"Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation","volume":"14","author":"Schulz","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0365","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/157015909789152128","article-title":"Tuning and fine-tuning of synapses with adenosine","volume":"7","author":"Sebasti\u00e3o","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0360","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1523\/JNEUROSCI.21-21-08564.2001","article-title":"Activation of synaptic NMDA receptors by action potential dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation","volume":"21","author":"Sebastiao","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0370","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signalling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.08.013_bb0375","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alterations in N-methyl-d-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease","volume":"82","author":"Starling","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.08.013_bb0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4615-0123-7_9","article-title":"Purines and neuroprotection","volume":"513","author":"Stone","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0385","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","volume":"193","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0390","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1745-7254.2005.00524.x","article-title":"Modulating effect of adenosine deaminase on function of adenosine A1 receptors","volume":"26","author":"Sun","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2014.08.013_bb0400","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A(2A) receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.013_bb0395","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","article-title":"MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 Inhibition","volume":"33","author":"Taylor","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0405","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1471-4159.2009.06282.x","article-title":"Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum","volume":"110","author":"Tebano","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0410","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","article-title":"Role of adenosine A2A receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease","volume":"10","author":"Tebano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.nbd.2014.08.013_bb0220","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.08.013_bb0420","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.013_bb0425","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.82.14.4857","article-title":"Adenosine-activated potassium conductance in cultured striatal neurons","volume":"82","author":"Trussell","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.013_bb0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/jme.0.0320129","article-title":"A1 adenosine receptors mediate hypoglycemia-induced neuronal injury","volume":"32","author":"Turner","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0430","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.08.013_bb0435","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington's disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2014.08.013_bb0440","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuropharm.2014.01.028","article-title":"TRR469, a potent A1 adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice","volume":"81C","author":"Vincenzi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.08.013_bb0445","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.STR.19.9.1133","article-title":"Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus","volume":"19","author":"von Lubitz","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2014.08.013_bb0450","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1523\/JNEUROSCI.18-01-00112.1998","article-title":"The mitogen-activated protein kinase p38\u20132 is necessary for the inhibition of N-type calcium current by bradykinin","volume":"18","author":"Wilk-Blaszczak","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0455","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0896-6273(94)90321-2","article-title":"Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus","volume":"12","author":"Wu","year":"1994","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.nbd.2014.08.013_bb0460","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0166-2236(96)01015-6","article-title":"Presynaptic inhibition of elicited neurotransmitter release","volume":"20","author":"Wu","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.08.013_bb0465","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728214.8.2.537","article-title":"Adenosine receptor agonists: from basic medicinal chemistry to clinical development","volume":"8","author":"Yan","year":"2003","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"25","key":"10.1016\/j.nbd.2014.08.013_bb0470","doi-asserted-by":"crossref","first-page":"22909","DOI":"10.1074\/jbc.M200042200","article-title":"p38 mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons","volume":"277","author":"Zhu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.08.013_bb0475","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s12035-013-8611-7","article-title":"The roles of p38 MAPK\/MSK1 signaling pathway in the neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in adult rats","volume":"49","author":"Zhu","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0485","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases Nat","volume":"5","author":"Zuccato","year":"2009","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.nbd.2014.08.013_bb0480","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.08.013_bb0495","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2014.08.013_bb0500","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01816-X","article-title":"Protective effect of adenosine receptor agonists in a new model of epilepsy-seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice","volume":"305","author":"Zuchora","year":"2001","journal-title":"Neurosci. Lett."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114002447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:17:22Z","timestamp":1746343042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":100,"alternative-id":["S0969996114002447"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.013","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}